LSBio
IHC-plus™ Polyclonal Goat anti-Human APOA4 Antibody (aa359-371, IHC, WB)

Anti-APOA4 antibody IHC of human small intestine. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody concentration 5 ug/ml.

IHC-plus™ Polyclonal Goat anti-Human APOA4 Antibody (aa359-371, IHC, WB)

Primary AntibodyLSBio Guarantee
Antibody:Goat Polyclonal
Applications:Enzyme-Linked Immunosorbent Assay, Immunohistochemistry (general), Immunohistochemistry, Paraffin, Western Blot
Reactivity:Human
Format:Liquid
See all APOA4 antibodies →
$383.00each
Catalog Number: LS-B2417-50

For bulk orders or custom formulations:

Request a Quote

Overview

Description
APOA4 antibody LS-B2417 is an unconjugated goat polyclonal antibody to human APOA4 (aa359-371). Validated for IHC, Peptide-ELISA and WB. Tested on 20 paraffin-embedded human tissues. Cited in 1 publication.
Application
ELISA, IHC, IHC-P, WB
Reactivity
Hu
Intended Use
Research Use Only
Guarantees
This product carries the LSBio 100% Guarantee.
Category
Antibodies > Primary Antibodies > Polyclonal Antibodies
Alternative Names
Apo-AIV | APOA4 | Apolipoprotein A-IV | Apolipoprotein A4 | ApoA-IV
Recommended Dilution: IHC-P
5 µg/ml
Recommended Dilution: WB
0.01 - 0.03 µg/ml
UniProt Number
P06727
SwissProt
P06727

Target

Target
APOA4
Antigen Species
Human
Specificity
Human APOA4.
Epitope
Human APOA4.

Antibody

Host Species
Goat
Clonality
Polyclonal
Origin Species
Human

Immunogen

Immunogen
Peptide with sequence C-KEKESQDKTLSLP, from the internal region (near the C-Terminus) of the protein sequence according to NP_000473.2.
Immunogen Type
Peptide

Format

Conjugate/Label
Unconjugated
Format
Liquid
Formulation
TBS, pH 7.3, 0.02% Sodium Azide, 0.5% BSA
Concentration
0.5 mg/mL
Animal Free
No
Carrier-Free
No
Preservative
Yes
Purification Method
Ammonium Sulfate Precipitation

Storage & Handling

Storage Conditions
Aliquot and store at -20°C. Avoid freeze-thaw cycles.
Recommended Storage Buffer
TBS
Identification of potential bladder cancer markers in urine by abundant-protein depletion coupled with quantitative proteomics. Chen CL, Lin TS, Tsai CH, Wu CC, Chung T, Chien KY, Wu M, Chang YS, Yu JS, Chen YT. Journal of proteomics. 2013 Jun;85:28-43. PubMed: 23631828

Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at: technical@vectorlabs.com.